{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:37:47Z","timestamp":1793144267006,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts","id":[{"id":"https:\/\/ror.org\/006k2kk72","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00125-026-06799-y","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:53:39Z","timestamp":1784210019000},"page":"3073-3087","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Imaging of MASLD: clinical standards and novel methods"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3875-3382","authenticated-orcid":false,"given":"Marc","family":"Jonuscheit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7795-584X","authenticated-orcid":false,"given":"Vera B.","family":"Schrauwen-Hinderling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"1","key":"6799_CR1","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/ANNALS-24-02933","volume":"178","author":"SMJ Ali","year":"2025","unstructured":"Ali SMJ, Lai M (2025) Metabolic dysfunction-associated steatotic liver disease. Ann Intern Med 178(1):ITC1\u2013ITC16. https:\/\/doi.org\/10.7326\/ANNALS-24-02933","journal-title":"Ann Intern Med"},{"issue":"11","key":"6799_CR2","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s00125-024-06196-3","volume":"67","author":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO)","year":"2024","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO) (2024) EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary. Diabetologia 67(11):2375\u20132392. https:\/\/doi.org\/10.1007\/s00125-024-06196-3","journal-title":"Diabetologia"},{"issue":"4","key":"6799_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L et al (2019) The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 71(4):793\u2013801. https:\/\/doi.org\/10.1016\/j.jhep.2019.06.021","journal-title":"J Hepatol"},{"issue":"2","key":"6799_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1053\/j.gastro.2023.04.025","volume":"165","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Wilson LA, Behling C et al (2023) Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study. Gastroenterology 165(2):463-472.e5. https:\/\/doi.org\/10.1053\/j.gastro.2023.04.025","journal-title":"Gastroenterology"},{"issue":"7","key":"6799_CR5","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.2337\/dc22-2048","volume":"46","author":"L Castera","year":"2023","unstructured":"Castera L, Laouenan C, Vallet-Pichard A et al (2023) High prevalence of NASH and advanced fibrosis in type 2 diabetes: a prospective study of 330 outpatients undergoing liver biopsies for elevated ALT, using a low threshold. Diabetes Care 46(7):1354\u20131362. https:\/\/doi.org\/10.2337\/dc22-2048","journal-title":"Diabetes Care"},{"issue":"5","key":"6799_CR6","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS et al (2023) AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77(5):1797\u20131835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"issue":"2","key":"6799_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","volume":"78","author":"B Fromenty","year":"2023","unstructured":"Fromenty B, Roden M (2023) Mitochondrial alterations in fatty liver diseases. J Hepatol 78(2):415\u2013429. https:\/\/doi.org\/10.1016\/j.jhep.2022.09.020","journal-title":"J Hepatol"},{"issue":"5","key":"6799_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","volume":"21","author":"C Koliaki","year":"2015","unstructured":"Koliaki C, Szendroedi J, Kaul K et al (2015) Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab 21(5):739\u2013746. https:\/\/doi.org\/10.1016\/j.cmet.2015.04.004","journal-title":"Cell Metab"},{"issue":"40","key":"6799_CR9","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","volume":"25","author":"G Ferraioli","year":"2019","unstructured":"Ferraioli G, Soares Monteiro LB (2019) Ultrasound-based techniques for the diagnosis of liver steatosis. World J Gastroenterol 25(40):6053\u20136062. https:\/\/doi.org\/10.3748\/wjg.v25.i40.6053","journal-title":"World J Gastroenterol"},{"issue":"1","key":"6799_CR10","doi-asserted-by":"publisher","first-page":"e222695","DOI":"10.1148\/radiol.222695","volume":"310","author":"D Kadi","year":"2024","unstructured":"Kadi D, Loomba R, Bashir MR (2024) Diagnosis and monitoring of nonalcoholic steatohepatitis: current state and future directions. Radiology 310(1):e222695. https:\/\/doi.org\/10.1148\/radiol.222695","journal-title":"Radiology"},{"issue":"4","key":"6799_CR11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3390\/cells9041005","volume":"9","author":"VA Piazzolla","year":"2020","unstructured":"Piazzolla VA, Mangia A (2020) Noninvasive diagnosis of NAFLD and NASH. Cells 9(4):1005. https:\/\/doi.org\/10.3390\/cells9041005","journal-title":"Cells"},{"issue":"11","key":"6799_CR12","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","volume":"36","author":"M Sasso","year":"2010","unstructured":"Sasso M, Beaugrand M, de Ledinghen V et al (2010) Controlled Attenuation Parameter (CAP): a novel VCTETM guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 36(11):1825\u20131835. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2010.07.005","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"6799_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/jod.jod_68_25","volume":"17","author":"V Damle","year":"2026","unstructured":"Damle V, Sharma A, Srivastava BK, Mohan V (2026) Imaging modalities for hepatic steatosis and fibrosis in type 2 diabetes mellitus: a review article. J Diabetol 17(1):18\u201323. https:\/\/doi.org\/10.4103\/jod.jod_68_25","journal-title":"J Diabetol"},{"issue":"6","key":"6799_CR14","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1002\/jmri.27703","volume":"54","author":"MA Troelstra","year":"2021","unstructured":"Troelstra MA, Witjes JJ, van Dijk A-M et al (2021) Assessment of imaging modalities against liver biopsy in nonalcoholic fatty liver disease: the Amsterdam NAFLD-NASH cohort. J Magn Reson Imaging 54(6):1937\u20131949. https:\/\/doi.org\/10.1002\/jmri.27703","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"6799_CR15","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","volume":"152","author":"CC Park","year":"2017","unstructured":"Park CC, Nguyen P, Hernandez C et al (2017) Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 152(3):598-607.e2. https:\/\/doi.org\/10.1053\/j.gastro.2016.10.026","journal-title":"Gastroenterology"},{"issue":"4","key":"6799_CR16","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.29639","volume":"67","author":"C Caussy","year":"2018","unstructured":"Caussy C, Alquiraish MH, Nguyen P et al (2018) Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology 67(4):1348\u20131359. https:\/\/doi.org\/10.1002\/hep.29639","journal-title":"Hepatology"},{"issue":"2","key":"6799_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/jmri.70148","volume":"63","author":"O Sa\u00efd","year":"2026","unstructured":"Sa\u00efd O, Doblas S, Paradis V et al (2026) Fat-corrected non-Gaussian diffusion MRI for liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease. J Magn Reson Imaging 63(2):497\u2013507. https:\/\/doi.org\/10.1002\/jmri.70148","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"6799_CR18","doi-asserted-by":"publisher","first-page":"umaf039","DOI":"10.1093\/radadv\/umaf039","volume":"2","author":"D Catucci","year":"2025","unstructured":"Catucci D, von Daeniken SU, Obmann VC et al (2025) Detection and severity stratification of chronic liver disease using magnetic resonance intravoxel incoherent motion and elastography. Radiol Adv 2(6):umaf039. https:\/\/doi.org\/10.1093\/radadv\/umaf039","journal-title":"Radiol Adv"},{"issue":"9","key":"6799_CR19","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1007\/s00261-022-03597-z","volume":"47","author":"RL Ehman","year":"2022","unstructured":"Ehman RL (2022) Magnetic resonance elastography: from invention to standard of care. Abdom Radiol (NY) 47(9):3028\u20133036. https:\/\/doi.org\/10.1007\/s00261-022-03597-z","journal-title":"Abdom Radiol (NY)"},{"issue":"7","key":"6799_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/nbm.1622","volume":"24","author":"G Hamilton","year":"2011","unstructured":"Hamilton G, Yokoo T, Bydder M et al (2011) In vivo characterization of the liver fat 1H MR spectrum. NMR Biomed 24(7):784\u2013790. https:\/\/doi.org\/10.1002\/nbm.1622","journal-title":"NMR Biomed"},{"key":"6799_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ab.2017.01.018","volume":"529","author":"L Valkovi\u010d","year":"2017","unstructured":"Valkovi\u010d L, Chmel\u00edk M, Kr\u0161\u0161\u00e1k M (2017) In-vivo 31P-MRS of skeletal muscle and liver: a way for non-invasive assessment of their metabolism. Anal Biochem 529:193\u2013215. https:\/\/doi.org\/10.1016\/j.ab.2017.01.018","journal-title":"Anal Biochem"},{"issue":"4","key":"6799_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/metabo12040321","volume":"12","author":"M-J Honka","year":"2022","unstructured":"Honka M-J, Rebelos E, Malaspina S, Nuutila P (2022) Hepatic positron emission tomography: applications in metabolism, haemodynamics and cancer. Metabolites 12(4):321. https:\/\/doi.org\/10.3390\/metabo12040321","journal-title":"Metabolites"},{"issue":"1","key":"6799_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s44355-025-00030-2","volume":"2","author":"MT Tantu","year":"2025","unstructured":"Tantu MT, Farhana FZ, Haque F et al (2025) Pathophysiology, noninvasive diagnostics and emerging personalized treatments for metabolic associated liver diseases. npj Gut Liver 2(1):18. https:\/\/doi.org\/10.1038\/s44355-025-00030-2","journal-title":"npj Gut Liver"},{"issue":"3","key":"6799_CR24","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"Hernaez R, Lazo M, Bonekamp S et al (2011) Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54(3):1082. https:\/\/doi.org\/10.1002\/hep.24452","journal-title":"Hepatology"},{"issue":"17","key":"6799_CR25","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.3748\/wjg.v29.i17.2534","volume":"29","author":"K-Y Zeng","year":"2023","unstructured":"Zeng K-Y, Bao W-Y-G, Wang Y-H et al (2023) Non-invasive evaluation of liver steatosis with imaging modalities: new techniques and applications. World J Gastroenterol 29(17):2534\u20132550. https:\/\/doi.org\/10.3748\/wjg.v29.i17.2534","journal-title":"World J Gastroenterol"},{"issue":"2","key":"6799_CR26","doi-asserted-by":"publisher","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","volume":"288","author":"LS Szczepaniak","year":"2005","unstructured":"Szczepaniak LS, Nurenberg P, Leonard D et al (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288(2):E462-468. https:\/\/doi.org\/10.1152\/ajpendo.00064.2004","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"6799_CR27","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1148\/radiol.14130863","volume":"271","author":"I Hwang","year":"2014","unstructured":"Hwang I, Lee JM, Lee KB et al (2014) Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy. Radiology 271(3):730\u2013738. https:\/\/doi.org\/10.1148\/radiol.14130863","journal-title":"Radiology"},{"issue":"5","key":"6799_CR28","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/hep.28012","volume":"62","author":"P Bannas","year":"2015","unstructured":"Bannas P, Kramer H, Hernando D et al (2015) Quantitative MR imaging of hepatic steatosis: validation in ex vivo human livers. Hepatology 62(5):1444\u20131455. https:\/\/doi.org\/10.1002\/hep.28012","journal-title":"Hepatology"},{"issue":"3","key":"6799_CR29","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1016\/j.ejrad.2009.03.062","volume":"74","author":"M Kr\u0161\u0161\u00e1k","year":"2010","unstructured":"Kr\u0161\u0161\u00e1k M, Hofer H, Wrba F et al (2010) Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy. Eur J Radiol 74(3):e60\u2013e66. https:\/\/doi.org\/10.1016\/j.ejrad.2009.03.062","journal-title":"Eur J Radiol"},{"issue":"2","key":"6799_CR30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1148\/radiol.2523082084","volume":"252","author":"N Pineda","year":"2009","unstructured":"Pineda N, Sharma P, Xu Q, Hu X, Vos M, Martin DR (2009) Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy\u2014a rapid and accurate technique. Radiology 252(2):568\u2013576. https:\/\/doi.org\/10.1148\/radiol.2523082084","journal-title":"Radiology"},{"issue":"1","key":"6799_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00330-010-1905-5","volume":"21","author":"AE Bohte","year":"2011","unstructured":"Bohte AE, van Werven JR, Bipat S, Stoker J (2011) The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 21(1):87\u201397. https:\/\/doi.org\/10.1007\/s00330-010-1905-5","journal-title":"Eur Radiol"},{"issue":"1","key":"6799_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2214\/AJR.16.16565","volume":"208","author":"H Kramer","year":"2017","unstructured":"Kramer H, Pickhardt PJ, Kliewer MA et al (2017) Accuracy of liver fat quantification with advanced CT, MRI, and ultrasound techniques: prospective comparison with MR spectroscopy. Am J Roentgenol 208(1):92\u2013100. https:\/\/doi.org\/10.2214\/AJR.16.16565","journal-title":"Am J Roentgenol"},{"issue":"8","key":"6799_CR33","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao Y-Y, Zheng M-H (2024) Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab 35(8):697\u2013707. https:\/\/doi.org\/10.1016\/j.tem.2024.02.007","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"6799_CR34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/00365521.2025.2594790","volume":"61","author":"M Byenfeldt","year":"2026","unstructured":"Byenfeldt M, Gr\u00f6nlund C, Nasr P et al (2026) A comparative study between ultrasound-guided-attenuation-parameter (UGAP), controlled attenuation parameter (CAP), and proton density fat fraction (PDFF) for assessment of hepatic steatosis. Scand J Gastroenterol 61(1):124\u2013132. https:\/\/doi.org\/10.1080\/00365521.2025.2594790","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"6799_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jhep.2024.03.023","volume":"81","author":"L Castera","year":"2024","unstructured":"Castera L, Garteiser P, Laouenan C et al (2024) Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes. J Hepatol 81(2):195\u2013206. https:\/\/doi.org\/10.1016\/j.jhep.2024.03.023","journal-title":"J Hepatol"},{"issue":"6","key":"6799_CR36","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","volume":"59","author":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO) (2016) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia 59(6):1121\u20131140. https:\/\/doi.org\/10.1007\/s00125-016-3902-y","journal-title":"Diabetologia"},{"issue":"8","key":"6799_CR37","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1478-3231.2012.02804.x","volume":"32","author":"S Ballestri","year":"2012","unstructured":"Ballestri S, Lonardo A, Romagnoli D et al (2012) Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. Liver Int 32(8):1242\u20131252. https:\/\/doi.org\/10.1111\/j.1478-3231.2012.02804.x","journal-title":"Liver Int"},{"key":"6799_CR38","doi-asserted-by":"publisher","first-page":"175628482412763","DOI":"10.1177\/17562848241276334","volume":"17","author":"D Hudson","year":"2024","unstructured":"Hudson D, Afzaal T, Bualbanat H et al (2024) Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques. Therap Adv Gastroenterol 17:17562848241276334. https:\/\/doi.org\/10.1177\/17562848241276334","journal-title":"Therap Adv Gastroenterol"},{"issue":"11","key":"6799_CR39","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1007\/s00261-020-02656-7","volume":"45","author":"IS Idilman","year":"2020","unstructured":"Idilman IS, Li J, Yin M, Venkatesh SK (2020) MR elastography of liver: current status and future perspectives. Abdom Radiol 45(11):3444\u20133462. https:\/\/doi.org\/10.1007\/s00261-020-02656-7","journal-title":"Abdom Radiol"},{"issue":"8","key":"6799_CR40","doi-asserted-by":"publisher","first-page":"8692700","DOI":"10.21037\/apm-21-1176","volume":"10","author":"J Bi","year":"2021","unstructured":"Bi J, Liu L, Qin T (2021) Comparison of magnetic resonance elastography and transient elastography in the diagnosis of hepatic fibrosis: a systematic review and meta-analysis. Ann Palliat Med 10(8):8692700\u20138698700. https:\/\/doi.org\/10.21037\/apm-21-1176","journal-title":"Ann Palliat Med"},{"issue":"4","key":"6799_CR41","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cgh.2018.05.059","volume":"17","author":"C Hsu","year":"2019","unstructured":"Hsu C, Caussy C, Imajo K et al (2019) Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants. Clin Gastroenterol Hepatol 17(4):630-637.e8. https:\/\/doi.org\/10.1016\/j.cgh.2018.05.059","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"6799_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.59556\/japi.73.1276","volume":"73","author":"MP Sharon","year":"2025","unstructured":"Sharon MP, Peer S, Raj A et al (2025) Quantification of liver stiffness using magnetic resonance elastography in comparison with transient elastography and noninvasive fibrosis score in fatty liver. JAPI 73(12):64\u201370. https:\/\/doi.org\/10.59556\/japi.73.1276","journal-title":"JAPI"},{"key":"6799_CR43","doi-asserted-by":"publisher","unstructured":"Sitarcikova D, Poetter-Lang S, Bastati N et al (2025) Diagnostic accuracy of texture analysis applied to T1- and T2-Relaxation maps for liver fibrosis classification via machine-learning algorithms with liver histology as reference standard. Eur J Radiol 183. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111887","DOI":"10.1016\/j.ejrad.2024.111887"},{"issue":"8","key":"6799_CR44","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1007\/s00330-020-06831-8","volume":"30","author":"K Schawkat","year":"2020","unstructured":"Schawkat K, Ciritsis A, von Ulmenstein S et al (2020) Diagnostic accuracy of texture analysis and machine learning for quantification of liver fibrosis in MRI: correlation with MR elastography and histopathology. Eur Radiol 30(8):4675\u20134685. https:\/\/doi.org\/10.1007\/s00330-020-06831-8","journal-title":"Eur Radiol"},{"issue":"1","key":"6799_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jmri.25146","volume":"44","author":"FE Mozes","year":"2016","unstructured":"Mozes FE, Tunnicliffe EM, Pavlides M, Robson MD (2016) Influence of fat on liver T1 measurements using modified Look-Locker inversion recovery (MOLLI) methods at 3T. J Magn Reson Imaging 44(1):105\u2013111. https:\/\/doi.org\/10.1002\/jmri.25146","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"6799_CR46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00261-018-1701-2","volume":"44","author":"A Mojtahed","year":"2019","unstructured":"Mojtahed A, Kelly CJ, Herlihy AH et al (2019) Reference range of liver corrected T1 values in a population at low risk for fatty liver disease-a UK Biobank sub-study, with an appendix of interesting cases. Abdom Radiol (NY) 44(1):72\u201384. https:\/\/doi.org\/10.1007\/s00261-018-1701-2","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"6799_CR47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cgh.2025.03.003","volume":"24","author":"A Andersson","year":"2026","unstructured":"Andersson A, Loomba R, Beyer C et al (2026) Change in cT1 following interventions in MASLD: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 24(2):355-364.e15. https:\/\/doi.org\/10.1016\/j.cgh.2025.03.003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6799_CR48","doi-asserted-by":"publisher","first-page":"575843","DOI":"10.3389\/fendo.2020.575843","volume":"11","author":"A Dennis","year":"2020","unstructured":"Dennis A, Kelly MD, Fernandes C et al (2020) Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis. Front Endocrinol (Lausanne) 11:575843. https:\/\/doi.org\/10.3389\/fendo.2020.575843","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"6799_CR49","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/jmri.28906","volume":"59","author":"FC Michelotti","year":"2024","unstructured":"Michelotti FC, Kupriyanova Y, Mori T et al (2024) An empirical approach to derive water T1 from multiparametric MR images using an automated pipeline and comparison with liver stiffness. J Magn Reson Imaging 59(4):1193\u20131203. https:\/\/doi.org\/10.1002\/jmri.28906","journal-title":"J Magn Reson Imaging"},{"issue":"10","key":"6799_CR50","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/RLI.0000000000001193","volume":"60","author":"N Mesropyan","year":"2025","unstructured":"Mesropyan N, Schneider F, Lutz PC et al (2025) Multiparametric MRI including T1\u03c1 mapping for hepatic fibrosis assessment in preclinical models of steatotic liver disease. Investig Radiol 60(10):679. https:\/\/doi.org\/10.1097\/RLI.0000000000001193","journal-title":"Investig Radiol"},{"key":"6799_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-025-12225-5","author":"N Mesropyan","year":"2025","unstructured":"Mesropyan N, Chang J, Lutz P et al (2025) Clinical validation of T1\u03c1 mapping for the assessment of hepatic fibrosis in patients with chronic liver disease. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-025-12225-5","journal-title":"Eur Radiol"},{"issue":"4","key":"6799_CR52","doi-asserted-by":"publisher","first-page":"e95700","DOI":"10.1371\/journal.pone.0095700","volume":"9","author":"MF Forsgren","year":"2014","unstructured":"Forsgren MF, Leinhard OD, Dahlstr\u00f6m N, Cedersund G, Lundberg P (2014) Physiologically realistic and validated mathematical liver model revels hepatobiliary transfer rates for Gd-EOB-DTPA using human DCE-MRI data. PLOS ONE 9(4):e95700. https:\/\/doi.org\/10.1371\/journal.pone.0095700","journal-title":"PLOS ONE"},{"issue":"3","key":"6799_CR53","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2214\/AJR.18.20012","volume":"212","author":"S Sarkar","year":"2019","unstructured":"Sarkar S, Corwin MT, Olson KA et al (2019) Pilot study to diagnose nonalcoholic steatohepatitis with dynamic 18F-FDG PET. Am J Roentgenol 212(3):529\u2013537. https:\/\/doi.org\/10.2214\/AJR.18.20012","journal-title":"Am J Roentgenol"},{"issue":"11","key":"6799_CR54","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/j.cgh.2020.10.029","volume":"19","author":"S Sarkar","year":"2021","unstructured":"Sarkar S, Matsukuma KE, Spencer B et al (2021) Dynamic positron emission tomography\/computed tomography imaging correlate of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 19(11):2441\u20132443. https:\/\/doi.org\/10.1016\/j.cgh.2020.10.029","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"6799_CR55","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s12149-025-02027-6","volume":"39","author":"Y Mori","year":"2025","unstructured":"Mori Y, Tamburini K, Novruzov E et al (2025) Efficacy of [68Ga]Ga-FAPI-PET as a non-invasive evaluation method of liver fibrosis. Ann Nucl Med 39(6):631\u2013639. https:\/\/doi.org\/10.1007\/s12149-025-02027-6","journal-title":"Ann Nucl Med"},{"key":"6799_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-34877-5","author":"L Li","year":"2026","unstructured":"Li L, Chen L, Peng D, Li M, Chen Y (2026) A pilot human-based study of 68Ga-FAPI-04 PET\/CT in staging liver fibrosis and preliminary comparison to FIB-4 and fibroscan. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-025-34877-5","journal-title":"Sci Rep"},{"key":"6799_CR57","doi-asserted-by":"publisher","unstructured":"Yang BQ, Chan MM, Heo GS et al (2024) Molecular imaging of macrophage composition and dynamics in MASLD. JHEPReport 6(12). https:\/\/doi.org\/10.1016\/j.jhepr.2024.101220","DOI":"10.1016\/j.jhepr.2024.101220"},{"issue":"1","key":"6799_CR58","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s41181-025-00410-2","volume":"10","author":"CN Yashaswini","year":"2025","unstructured":"Yashaswini CN, Mitran B, Papadopoulos N et al (2025) PDGFR\u00df targeted positron emission tomography as a non-invasive biomarker for activated hepatic stellate cells: lasts steps before clinical translation. EJNMMI Radiopharm Chem 10(1):80. https:\/\/doi.org\/10.1186\/s41181-025-00410-2","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"4","key":"6799_CR59","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1021\/acsnano.1c10618","volume":"16","author":"YL Balachandran","year":"2022","unstructured":"Balachandran YL, Wang W, Yang H et al (2022) Heterogeneous iron oxide\/dysprosium oxide nanoparticles target liver for precise magnetic resonance imaging of liver fibrosis. ACS Nano 16(4):5647\u20135659. https:\/\/doi.org\/10.1021\/acsnano.1c10618","journal-title":"ACS Nano"},{"issue":"1","key":"6799_CR60","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00259-024-06894-5","volume":"52","author":"S Wu","year":"2024","unstructured":"Wu S, Xu T, Gao J et al (2024) Non-invasive diagnosis of liver fibrosis via MRI using targeted gadolinium-based nanoparticles. Eur J Nucl Med Mol Imaging 52(1):48\u201361. https:\/\/doi.org\/10.1007\/s00259-024-06894-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"6799_CR61","doi-asserted-by":"publisher","first-page":"101025","DOI":"10.1016\/j.ajps.2025.101025","volume":"20","author":"F Li","year":"2025","unstructured":"Li F, Yuan R, Zhang J, Su B, Qi X (2025) Advances in nanotechnology for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease. Asian J Pharm Sci 20(2):101025. https:\/\/doi.org\/10.1016\/j.ajps.2025.101025","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"6799_CR62","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1055\/a-2157-2587","volume":"45","author":"CF Dietrich","year":"2024","unstructured":"Dietrich CF, Correas J-M, Cui X-W et al (2024) EFSUMB technical review - update 2023: dynamic contrast-enhanced ultrasound (DCE-CEUS) for the quantification of tumor perfusion. Ultraschall Med 45(1):36\u201346. https:\/\/doi.org\/10.1055\/a-2157-2587","journal-title":"Ultraschall Med"},{"issue":"3","key":"6799_CR63","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jhep.2014.10.014","volume":"62","author":"BEV Beers","year":"2015","unstructured":"Beers BEV, Daire J-L, Garteiser P (2015) New imaging techniques for liver diseases. J Hepatol 62(3):690\u2013700. https:\/\/doi.org\/10.1016\/j.jhep.2014.10.014","journal-title":"J Hepatol"},{"issue":"11","key":"6799_CR64","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/RLI.0000000000000286","volume":"51","author":"N Bastati","year":"2016","unstructured":"Bastati N, Wibmer A, Tamandl D et al (2016) Assessment of orthotopic liver transplant graft survival on gadoxetic acid-enhanced magnetic resonance imaging using qualitative and quantitative parameters. Investig Radiol 51(11):728. https:\/\/doi.org\/10.1097\/RLI.0000000000000286","journal-title":"Investig Radiol"},{"issue":"10","key":"6799_CR65","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1007\/s00330-018-5366-6","volume":"28","author":"K Sandrasegaran","year":"2018","unstructured":"Sandrasegaran K, Cui E, Elkady R et al (2018) Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis? Eur Radiol 28(10):4215\u20134224. https:\/\/doi.org\/10.1007\/s00330-018-5366-6","journal-title":"Eur Radiol"},{"issue":"1","key":"6799_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13244-025-02187-z","volume":"17","author":"H \u00d6zen Atalay","year":"2026","unstructured":"\u00d6zen Atalay H, Sogut MS, Akyildiz M, Durur Karakaya A (2026) Incorporating parenchymal heterogeneity into FLIS to improve MRI-based liver function assessment. Insights Imaging 17(1):11. https:\/\/doi.org\/10.1186\/s13244-025-02187-z","journal-title":"Insights Imaging"},{"issue":"4","key":"6799_CR67","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/jmri.28372","volume":"57","author":"LWF Seelen","year":"2023","unstructured":"Seelen LWF, van den Wildenberg L, van der Kemp WJM et al (2023) Prospective of 31 P MR spectroscopy in hepatopancreatobiliary cancer: a systematic review of the literature. J Magn Reson Imaging 57(4):1144\u20131155. https:\/\/doi.org\/10.1002\/jmri.28372","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"6799_CR68","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1148\/radiol.10091351","volume":"256","author":"K Sevastianova","year":"2010","unstructured":"Sevastianova K, Hakkarainen A, Kotronen A et al (2010) Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling. Radiology 256(2):466\u2013473. https:\/\/doi.org\/10.1148\/radiol.10091351","journal-title":"Radiology"},{"issue":"16","key":"6799_CR69","doi-asserted-by":"publisher","first-page":"8731","DOI":"10.3390\/ijms25168731","volume":"25","author":"S-E Ferdous","year":"2024","unstructured":"Ferdous S-E, Ferrell JM (2024) Pathophysiological relationship between type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: novel therapeutic approaches. Int J Mol Sci 25(16):8731. https:\/\/doi.org\/10.3390\/ijms25168731","journal-title":"Int J Mol Sci"},{"issue":"12","key":"6799_CR70","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3390\/metabo12121223","volume":"12","author":"A Gursan","year":"2022","unstructured":"Gursan A, Prompers JJ (2022) Magnetic resonance imaging and spectroscopy methods to study hepatic glucose metabolism and their applications in the healthy and diabetic liver. Metabolites 12(12):1223. https:\/\/doi.org\/10.3390\/metabo12121223","journal-title":"Metabolites"},{"issue":"8","key":"6799_CR71","doi-asserted-by":"publisher","first-page":"e5120","DOI":"10.1002\/nbm.5120","volume":"37","author":"M Jonuscheit","year":"2024","unstructured":"Jonuscheit M, Wierichs S, Rothe M et al (2024) Reproducibility of absolute quantification of adenosine triphosphate and inorganic phosphate in the liver with localized 31P-magnetic resonance spectroscopy at 3-T using different coils. NMR Biomed 37(8):e5120. https:\/\/doi.org\/10.1002\/nbm.5120","journal-title":"NMR Biomed"},{"issue":"4","key":"6799_CR72","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/hep.23093","volume":"50","author":"J Szendroedi","year":"2009","unstructured":"Szendroedi J, Chmelik M, Schmid AI et al (2009) Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology 50(4):1079\u20131086. https:\/\/doi.org\/10.1002\/hep.23093","journal-title":"Hepatology"},{"issue":"2","key":"6799_CR73","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/jmri.26225","volume":"49","author":"L Pfleger","year":"2019","unstructured":"Pfleger L, Gajdo\u0161\u00edk M, Wolf P et al (2019) Absolute quantification of phosphor-containing metabolites in the liver using 31P MRSI and hepatic lipid volume correction at 7T suggests no dependence on body mass index or age. J Magn Reson Imaging 49(2):597\u2013607. https:\/\/doi.org\/10.1002\/jmri.26225","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"6799_CR74","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s41747-025-00588-9","volume":"9","author":"M Jonuscheit","year":"2025","unstructured":"Jonuscheit M, Korzekwa B, Sch\u00e4r M et al (2025) 31P-MRS saturation transfer for assessing human hepatic ATP synthesis at clinical field strength. Eur Radiol Exp 9(1):51. https:\/\/doi.org\/10.1186\/s41747-025-00588-9","journal-title":"Eur Radiol Exp"},{"issue":"2","key":"6799_CR75","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2337\/dc10-1076","volume":"34","author":"AI Schmid","year":"2011","unstructured":"Schmid AI, Szendroedi J, Chmelik M, Krss\u00e1k M, Moser E, Roden M (2011) Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care 34(2):448\u2013453. https:\/\/doi.org\/10.2337\/dc10-1076","journal-title":"Diabetes Care"},{"issue":"7","key":"6799_CR76","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s00330-014-3141-x","volume":"24","author":"L Valkovi\u010d","year":"2014","unstructured":"Valkovi\u010d L, Gajdo\u0161\u00edk M, Traussnigg S et al (2014) Application of localized 31P MRS saturation transfer at 7 T for measurement of ATP metabolism in the liver: reproducibility and initial clinical application in patients with non-alcoholic fatty liver disease. Eur Radiol 24(7):1602\u20131609. https:\/\/doi.org\/10.1007\/s00330-014-3141-x","journal-title":"Eur Radiol"},{"issue":"10","key":"6799_CR77","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1111\/liv.13451","volume":"37","author":"S Traussnigg","year":"2017","unstructured":"Traussnigg S, Kienbacher C, Gajdo\u0161\u00edk M et al (2017) Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis. Liver Int 37(10):1544\u20131553. https:\/\/doi.org\/10.1111\/liv.13451","journal-title":"Liver Int"},{"issue":"5031","key":"6799_CR78","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1126\/science.1948033","volume":"254","author":"DL Rothman","year":"1991","unstructured":"Rothman DL, Magnusson I, Katz LD, Shulman RG, Shulman GI (1991) Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 254(5031):573\u2013576. https:\/\/doi.org\/10.1126\/science.1948033","journal-title":"Science"},{"issue":"1","key":"6799_CR79","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nm.3415","volume":"20","author":"DE Befroy","year":"2014","unstructured":"Befroy DE, Perry RJ, Jain N et al (2014) Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic 13C magnetic resonance spectroscopy. Nat Med 20(1):98\u2013102. https:\/\/doi.org\/10.1038\/nm.3415","journal-title":"Nat Med"},{"issue":"11","key":"6799_CR80","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.2337\/db12-0558","volume":"61","author":"DE Befroy","year":"2012","unstructured":"Befroy DE, Rothman DL, Petersen KF, Shulman GI (2012) 31P-magnetization transfer magnetic resonance spectroscopy measurements of in vivo metabolism. Diabetes 61(11):2669\u20132678. https:\/\/doi.org\/10.2337\/db12-0558","journal-title":"Diabetes"},{"issue":"12","key":"6799_CR81","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.2337\/db16-0804","volume":"65","author":"AJM Lewis","year":"2016","unstructured":"Lewis AJM, Miller JJJ, McCallum C et al (2016) Assessment of metformin-induced changes in cardiac and hepatic redox state using hyperpolarized[1-13C]pyruvate. Diabetes 65(12):3544\u20133551. https:\/\/doi.org\/10.2337\/db16-0804","journal-title":"Diabetes"},{"key":"6799_CR82","doi-asserted-by":"publisher","first-page":"156151","DOI":"10.1016\/j.metabol.2025.156151","volume":"165","author":"JM Park","year":"2025","unstructured":"Park JM, Lin S-H, Baxter JD et al (2025) Disrupted metabolic flux balance between pyruvate dehydrogenase and pyruvate carboxylase in human fatty liver. Metabolism 165:156151. https:\/\/doi.org\/10.1016\/j.metabol.2025.156151","journal-title":"Metabolism"},{"issue":"3","key":"6799_CR83","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00125-023-06055-7","volume":"67","author":"J Basset-Sagarminaga","year":"2024","unstructured":"Basset-Sagarminaga J, van de Weijer T, Iozzo P, Schrauwen P, Schrauwen-Hinderling V (2024) Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research. Diabetologia 67(3):407\u2013419. https:\/\/doi.org\/10.1007\/s00125-023-06055-7","journal-title":"Diabetologia"},{"key":"6799_CR84","doi-asserted-by":"publisher","first-page":"1578333","DOI":"10.3389\/fendo.2025.1578333","volume":"16","author":"Y Kupriyanova","year":"2025","unstructured":"Kupriyanova Y, Schrauwen-Hinderling V (2025) Advances in in vivo magnetic resonance spectroscopy for metabolic disorders. Front Endocrinol (Lausanne) 16:1578333. https:\/\/doi.org\/10.3389\/fendo.2025.1578333","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06799-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06799-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06799-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:39:09Z","timestamp":1790771949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-026-06799-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":84,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["6799"],"URL":"https:\/\/doi.org\/10.1007\/s00125-026-06799-y","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors would like to thank F. Battiato, D. M. M\u00e9ndez C\u00e1rdenas and M. Varadinova, members of the Clinical Research Center (CRC) at the Institute for Clinical Diabetology, German Diabetes Center (DDZ). The authors also thank T. van de Weijer, Department of Radiology of the Maastricht University Medical Center, Maastricht UMC+.","order":1,"name":"Ethics","label":"Acknowledgements","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This article reviews only data extracted from published sources in the public domain.","order":2,"name":"Ethics","label":"Data availability","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors are supported by the German Diabetes Center (DDZ), which is funded by the German Federal Ministry of Health (BMG, Berlin, Germany) and the Ministry of Culture and Science of Northrhine-Westphalia (MKW-NRW, D\u00fcsseldorf, Germany) and as a multicentre study now receives additional funding from the German Federal Ministry of Education and Research (BMBF, Berlin, Germany) through the German Center for Diabetes Research (DZD).","order":3,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"VS-H is a member of the editorial board of Diabetologia. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Both authors drafted the manuscript. Both authors reviewed the manuscript and approved the final version for publication.","order":5,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}